Premium
Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI Venture way back in 1996 when PE was a new term in India. Today, the drugmaker counts Indian PE firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
